Dementia with Lewy Bodies Consortium

Short description: International multidisciplinary researcher collaboration

The Dementia with Lewy Bodies Consortium (DLB Consortium or DLBC) is an international multidisciplinary collaboration of researchers interested in the dementia with Lewy bodies.[1] It first convened in Newcastle upon Tyne, England, in October 1995.[1] Between 1995 and 2005, it issued three DLBC Consensus Reports on dementia with Lewy bodies.[2]

## Contents

* 1 Fourth Consensus Report
* 2 DLBC 2015
* 3 Sources
* 4 References
* 5 External links

## Fourth Consensus Report

The 2017 rewrite of the diagnostic criteria for DLB[3] was led by Ian G. McKeith of Newcastle University and supported by The National Institute on Aging, National Institutes of Neurological Disorders and Stroke, the Lewy Body Dementia Association, the Lewy Body Society, Alzheimer’s Association, Acadia Pharmaceuticals, Axovant Sciences, Banner Health, GE Healthcare, and Lundbeck.[4]

## DLBC 2015

The 2015 DLBC in the United States is a project of the Parkinson's Disease BioMarker Program of the National Institute of Neurological Disorders and Stroke that "establishes a group of centers dedicated to the study of dementia with Lewy bodies (DLB) ... to allow for the discovery of a biomarker for DLB to improve the diagnosis, care, and treatment of patients with this disease".[5]

As of 2020, it includes nine centers that have Lewy body dementia experts who have "strong connections to the Lewy body dementia research and general community".[5] The DLBC will "formalize and strengthen already existing collaboration among the participating centers".[6] The nine centers as of 2018 are:[5]

* Cleveland Clinic
* Florida Atlantic University
* Thomas Jefferson University
* Rush University
* University of California San Diego
* University of North Carolina
* University of Pennsylvania
* University of Pittsburgh
* VA Puget Sound Health Care System - University of Washington

The DLBC is funded by a "$6 million, five-year grant from the National Institutes of Health";[6] it was also funded by the Lewy Body Dementia Association and GE Healthcare.[6]

## Sources

* "Chapter 5: Clinical diagnostic criteria for dementia with Lewy bodies". Dementia with Lewy bodies: clinical and biological aspects (1st ed.). Japan: Springer. 2017. doi:10.1007/978-4-431-55948-1. ISBN 978-4-431-55948-1.

## References

1. ↑ 1.0 1.1 McKeith IG in Kosaka K, ed. (2017), pp. 63–64.
2. ↑ McKeith IG in Kosaka K, ed. (2017), pp. 64–67.
3. ↑ "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium". Neurology 89 (1): 88–100. July 2017. doi:10.1212/WNL.0000000000004058. PMID 28592453.
4. ↑ "New Diagnostic Criteria Published for DLB". Lewy Body Dementia Association, Inc.. 2016. https://www.lbda.org/newdlbcriteria. Retrieved March 22, 2018.
5. ↑ 5.0 5.1 5.2 "Dementia with Lewy Bodies Consortium (U01): Summary". Parkinson's Disease Biomarker Program. National Institute of Neurological Disorders and Stroke. https://pdbp.ninds.nih.gov/Dementia-with-Lewy-Bodies-Consortium. Retrieved May 14, 2020.
6. ↑ 6.0 6.1 6.2 Leverenz, James and Babak Tousi (October 2, 2017). "New Research Consortium Gives Dementia with Lewy Bodies Its Due" (Press release). Cleveland Clinic. Retrieved March 22, 2018. Also Press release

## External links

* Official website of US DLBC
* "Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop". J. Alzheimers Dis. 9 (3 Suppl): 417–23. 2006. doi:10.3233/JAD-2006-9S347. PMID 16914880.

* v
* t
* e

US National Institutes of Health

Institutes|

* National Cancer Institute
* National Eye Institute
* National Heart, Lung, and Blood Institute
* National Human Genome Research Institute
* National Institute on Aging
* National Institute on Alcohol Abuse and Alcoholism
* National Institute of Allergy and Infectious Diseases
* National Institute of Arthritis and Musculoskeletal and Skin Diseases
* National Institute of Biomedical Imaging and Bioengineering
* National Institute of Child Health and Human Development
* National Institute on Deafness and Other Communication Disorders
* National Institute of Dental and Craniofacial Research
* National Institute of Diabetes and Digestive and Kidney Diseases
* National Institute on Drug Abuse
* National Institute of Environmental Health Sciences
* National Institute of General Medical Sciences
* National Institute of Mental Health
* National Institute on Minority Health and Health Disparities
* National Institute of Neurological Disorders and Stroke
* National Institute of Nursing Research
* National Library of Medicine

Centers|

* Center for Information Technology
* Center for Scientific Review
* John E. Fogarty International Center
* National Center for Complementary and Integrative Health
* National Center for Advancing Translational Sciences
* Vaccine Research Center
* National Institutes of Health Clinical Center

Programs|

* Visible Human Project
* National Diabetes Education Program

Directors|

* Joseph J. Kinyoun
* Milton J. Rosenau
* John F. Anderson
* George W. McCoy
* Lewis R. Thompson
* Rolla Dyer
* William H. Sebrell, Jr
* James Augustine Shannon
* Robert Q. Marston
* Robert Stone
* Donald S. Fredrickson
* James B. Wyngaarden
* Bernadine Healy
* Harold E. Varmus
* Elias Zerhouni
* Francis Collins

Related|

* NIH Record
* United States Public Health Service
* Division of Intramural Research
* National Institutes of Health campus
* National Institutes of Health Director's Pioneer Award
* NIH Public Access Policy
* National Center for Research Resources
* National Institutes of Health Police
* Office of Laboratory Animal Welfare

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Dementia with Lewy Bodies Consortium. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Organization:Dementia_with_Lewy_Bodies_Consortium&oldid=4110143"
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template